Literature DB >> 23335482

Schizophrenia two-hit hypothesis in velo-cardio facial syndrome.

Hywel J Williams1, Stephen Monks, Kieran C Murphy, George Kirov, Michael C O'Donovan, Michael J Owen.   

Abstract

Deletion of chr22q11 gives rise to velo-cardio facial syndrome (VCFS) and increases schizophrenia risk. The source of this elevated risk although unknown could result from stochastic, environmental, or genetic factors, the latter encompassing a range of complexity from polygenic mechanisms to "second-hit" mutations. For this study we tested the two-hit hypothesis where additional risk is conferred through a second CNV. We identified large (>100 kb) CNVs in 48 VCFS cases (23 with psychosis--25 without) and show in the psychotic VCFS group there is a significant (P = 0.02) increase in the average size of CNVs (354-227 kb). To identify second-hit loci we focused on individuals possessing gene-centric CNVs and through literature mining identified 4 (31%) psychotic VCFS individuals (n = 13) that overlapped loci previously implicated in neuropsychiatric disorders compared to 1 (10%) from the non-psychotic VCFS individuals (n = 10). For replication 17 VCFS patients with schizophrenia from the molecular genetics of schizophrenia dataset were used to identify further CNVs. Thirteen individuals possessing gene-centric CNVs were identified including 3 (23%) individuals possessing a potential second-hit, taking the overall total in the psychotic VCFS group (n = 26) to 7 (27%) potential second-hit loci. Notably a deletion in a psychotic VCFS patient at 2q23.1 hit the gene MBD5 which when deleted gives rise to intellectual disability, epilepsy, and autistic features. Through this study we potentially extend this phenotypic spectrum to include schizophrenia. Our results suggest the two-hit hypothesis may be relevant to a proportion of VCFS patients with psychosis but sample sizes are small and further studies warranted.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23335482     DOI: 10.1002/ajmg.b.32129

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  10 in total

1.  Formation of chimeric genes by copy-number variation as a mutational mechanism in schizophrenia.

Authors:  Caitlin Rippey; Tom Walsh; Suleyman Gulsuner; Matt Brodsky; Alex S Nord; Molly Gasperini; Sarah Pierce; Cailyn Spurrell; Bradley P Coe; Niklas Krumm; Ming K Lee; Jonathan Sebat; Jon M McClellan; Mary-Claire King
Journal:  Am J Hum Genet       Date:  2013-10-03       Impact factor: 11.025

2.  Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.

Authors:  Anne S Bassett; Chelsea Lowther; Daniele Merico; Gregory Costain; Eva W C Chow; Therese van Amelsvoort; Donna McDonald-McGinn; Raquel E Gur; Ann Swillen; Marianne Van den Bree; Kieran Murphy; Doron Gothelf; Carrie E Bearden; Stephan Eliez; Wendy Kates; Nicole Philip; Vandana Sashi; Linda Campbell; Jacob Vorstman; Joseph Cubells; Gabriela M Repetto; Tony Simon; Erik Boot; Tracy Heung; Rens Evers; Claudia Vingerhoets; Esther van Duin; Elaine Zackai; Elfi Vergaelen; Koen Devriendt; Joris R Vermeesch; Michael Owen; Clodagh Murphy; Elena Michaelovosky; Leila Kushan; Maude Schneider; Wanda Fremont; Tiffany Busa; Stephen Hooper; Kathryn McCabe; Sasja Duijff; Karin Isaev; Giovanna Pellecchia; John Wei; Matthew J Gazzellone; Stephen W Scherer; Beverly S Emanuel; Tingwei Guo; Bernice E Morrow; Christian R Marshall
Journal:  Am J Psychiatry       Date:  2017-07-28       Impact factor: 18.112

Review 3.  Explaining additional genetic variation in complex traits.

Authors:  Matthew R Robinson; Naomi R Wray; Peter M Visscher
Journal:  Trends Genet       Date:  2014-03-11       Impact factor: 11.639

Review 4.  Allostatic Load and Preterm Birth.

Authors:  David M Olson; Emily M Severson; Barbara S E Verstraeten; Jane W Y Ng; J Keiko McCreary; Gerlinde A S Metz
Journal:  Int J Mol Sci       Date:  2015-12-15       Impact factor: 5.923

5.  High resolution analysis of rare copy number variants in patients with autism spectrum disorder from Taiwan.

Authors:  Chia-Hsiang Chen; Hsin-I Chen; Wei-Hsien Chien; Ling-Hui Li; Yu-Yu Wu; Yen-Nan Chiu; Wen-Che Tsai; Susan Shur-Fen Gau
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

6.  Deletion Extents Are Not the Cause of Clinical Variability in 22q11.2 Deletion Syndrome: Does the Interaction between DGCR8 and miRNA-CNVs Play a Major Role?

Authors:  Veronica Bertini; Alessia Azzarà; Annalisa Legitimo; Roberta Milone; Roberta Battini; Rita Consolini; Angelo Valetto
Journal:  Front Genet       Date:  2017-05-01       Impact factor: 4.599

7.  No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patients.

Authors:  M Guipponi; F Santoni; M Schneider; C Gehrig; X B Bustillo; W R Kates; B Morrow; M Armando; S Vicari; F Sloan-Béna; M Gagnebin; V Shashi; S R Hooper; S Eliez; S E Antonarakis
Journal:  Transl Psychiatry       Date:  2017-02-21       Impact factor: 6.222

8.  Risk gene-set and pathways in 22q11.2 deletion-related schizophrenia: a genealogical molecular approach.

Authors:  Elena Michaelovsky; Miri Carmel; Amos Frisch; Mali Salmon-Divon; Metsada Pasmanik-Chor; Abraham Weizman; Doron Gothelf
Journal:  Transl Psychiatry       Date:  2019-01-17       Impact factor: 6.222

9.  Whole-Genome Sequencing Suggests Schizophrenia Risk Mechanisms in Humans with 22q11.2 Deletion Syndrome.

Authors:  Daniele Merico; Mehdi Zarrei; Gregory Costain; Lucas Ogura; Babak Alipanahi; Matthew J Gazzellone; Nancy J Butcher; Bhooma Thiruvahindrapuram; Thomas Nalpathamkalam; Eva W C Chow; Danielle M Andrade; Brendan J Frey; Christian R Marshall; Stephen W Scherer; Anne S Bassett
Journal:  G3 (Bethesda)       Date:  2015-09-16       Impact factor: 3.154

10.  Differential DNA methylation at birth associated with mental disorder in individuals with 22q11.2 deletion syndrome.

Authors:  A Starnawska; C S Hansen; T Sparsø; W Mazin; L Olsen; M Bertalan; A Buil; J Bybjerg-Grauholm; M Bækvad-Hansen; D M Hougaard; P B Mortensen; C B Pedersen; M Nyegaard; T Werge; S Weinsheimer
Journal:  Transl Psychiatry       Date:  2017-08-29       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.